Charles Harris

Charles Harris has a comprehensive work history in the field of tax and finance. Charles is currently employed as the Senior Director Tax at ACADIA Pharmaceuticals Inc. since March 2020. Prior to this, they held the position of Director, Tax and Insurance at Halozyme Therapeutics, Inc. from April 2016 to March 2020. Charles also served as the Director of Tax at Arena Pharmaceuticals from September 2013 to March 2016. Before that, they worked as the Tax Lead at BioLegend, Inc. from January 2011 to August 2013. Their earlier experience includes working as a Corporate Tax Professional at Corporate Tax and Business from August 2010 to January 2011. Charles has also held senior positions such as Senior Director, Corporate Tax at Elan Pharmaceuticals, Inc. from November 2000 to July 2010, and Director of Tax at Dura Pharmaceuticals, Inc. from April 1999 to November 2000. Charles started their career as a Tax Manager at Mycogen Corporation in January 1993, where they managed the tax group and oversaw tax issues for various subsidiaries. Charles also has previous experience as a Tax Manager at Ernst & Young from 1987 to 1992. Throughout their career, Charles has developed expertise in tax planning, transfer pricing, and representation in IRS and State Audits.

Charles Harris pursued their education at San Diego State University, where they obtained a Masters degree in Tax Accounting from 1979 to 1987. Additionally, they earned another Masters degree in Tax from the same institution, although the duration for this degree remains unknown. Charles specialized in Finance and Tax during their studies.